IRIS
SOLFRIZZI, Vincenzo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.496
EU - Europa 2.751
AS - Asia 1.368
OC - Oceania 31
AF - Africa 10
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 20.661
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.486
CN - Cina 939
SE - Svezia 682
UA - Ucraina 481
DE - Germania 390
IT - Italia 370
FI - Finlandia 280
SG - Singapore 255
GB - Regno Unito 167
FR - Francia 131
IE - Irlanda 61
NL - Olanda 56
VN - Vietnam 56
IN - India 51
RU - Federazione Russa 43
AU - Australia 29
BE - Belgio 29
RO - Romania 18
HK - Hong Kong 17
IR - Iran 12
CA - Canada 10
GR - Grecia 8
JP - Giappone 7
CZ - Repubblica Ceca 5
ES - Italia 5
TH - Thailandia 5
AL - Albania 4
KR - Corea 4
PL - Polonia 4
ZA - Sudafrica 4
AT - Austria 3
KZ - Kazakistan 3
BG - Bulgaria 2
CH - Svizzera 2
EG - Egitto 2
EU - Europa 2
ID - Indonesia 2
IL - Israele 2
KE - Kenya 2
LU - Lussemburgo 2
MA - Marocco 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PE - Perù 2
PH - Filippine 2
PT - Portogallo 2
TR - Turchia 2
TW - Taiwan 2
YE - Yemen 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BR - Brasile 1
HR - Croazia 1
LK - Sri Lanka 1
LT - Lituania 1
MY - Malesia 1
OM - Oman 1
PK - Pakistan 1
RS - Serbia 1
UZ - Uzbekistan 1
Totale 20.661
Salva come PNG Salva come JPEG
Città #
Fairfield 2.576
Woodbridge 2.046
Houston 1.374
Chandler 1.258
Ashburn 1.224
Jacksonville 1.117
Seattle 1.102
Ann Arbor 889
Cambridge 858
Wilmington 782
Nyköping 552
Roxbury 296
Lawrence 295
Nanjing 288
Singapore 212
Des Moines 205
Beijing 194
Boardman 158
New York 117
Princeton 112
San Diego 95
Bari 94
Nanchang 68
Santa Clara 68
Brooklyn 65
Shenyang 62
Inglewood 61
Dublin 59
Hebei 56
Dearborn 55
Jiaxing 49
Los Angeles 43
Paris 41
Strasbourg 39
Dong Ket 38
Ostuni 36
Changsha 35
Tianjin 35
Pune 34
Ruvo Di Puglia 32
Brussels 29
London 29
Washington 27
Redwood City 25
Norwalk 18
San Mateo 18
Helsinki 17
Chanh Hiep 16
Guangzhou 15
Melbourne 15
Auburn Hills 13
Falls Church 13
Leawood 13
Redmond 13
San Francisco 13
Scottsdale 12
Shanghai 12
Taranto 12
Groningen 11
Augusta 10
Ardabil 9
Hong Kong 9
Henderson 8
Kilburn 8
Las Vegas 8
San Jose 8
Sydney 8
Hefei 7
Milan 7
Ningbo 7
Foggia 6
Munich 6
Rome 6
San Genesio Ed Uniti 6
Wuhan 6
Acton 5
Bangkok 5
Canberra 5
Central 5
Monmouth Junction 5
Prescot 5
Toronto 5
Zhengzhou 5
Amsterdam 4
Chiswick 4
Haikou 4
Moscow 4
New Bedfont 4
Palermo 4
Phoenix 4
Tübingen 4
West Palm Beach 4
Xian 4
Buffalo 3
Chicago 3
Chongqing 3
Corfu 3
Cutrofiano 3
Detroit 3
Florence 3
Totale 17.261
Salva come PNG Salva come JPEG
Nome #
Prevalence of cognitive impairment and dementia in a population based study in Southern Italy: The Great Age study 259
Coffee, tea, and caffeine consumption and prevention of late-life cognitive decline and dementia: A systematic review 212
Additive Role of a Potentially Reversible Cognitive Frailty Model and Inflammatory State on the Risk of Disability: The Italian Longitudinal Study on Aging 170
Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer's Disease and Late-Life Cognitive Disorders: A Systematic Review 166
Age-related hearing impairment—a risk factor and frailty marker for dementia and AD 159
Reversible Cognitive Frailty, Dementia, and All-Cause Mortality. The Italian Longitudinal Study on Aging 142
Nutritional Intervention as a Preventive Approach for Cognitive-Related Outcomes in Cognitively Healthy Older Adults: A Systematic Review 140
Targeting Cognitive Frailty: Clinical and Neurobiological Roadmap for a Single Complex Phenotype 134
Coffee consumption habits and the risk of mild cognitive impairment: The Italian longitudinal study on aging 131
Cognitive Frailty: A Systematic Review of Epidemiological and Neurobiological Evidence of an Age-Related Clinical Condition 130
Innovative biomarkers in psychiatric disorders: a major clinical challenge in psychiatry 126
Biopsychosocial frailty and the risk of incident dementia: The Italian longitudinal study on aging 125
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease 117
Age-related hearingimpairment and frailty in Alzheimer’s disease: interconnected associations and mechanisms 113
Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease. 112
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing 111
Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients 109
Different Cognitive Frailty Models and Health- and Cognitive-related Outcomes in Older Age: From Epidemiology to Prevention 108
Tau-based therapeutics for Alzheimer's disease: Active and passive immunotherapy 107
High doses of incobotulinumtoxinA for the treatment of post-stroke spasticity: are they safe and effective? 106
The prevalence of peripheral and central hearing impairment and its relation to cognition in older adults 106
Vascular risk factors, alcohol intake, and cognitive decline 105
Progresses in treating agitation: a major clinical challenge in Alzheimer’s disease 105
Tau aggregation inhibitors: The future of Alzheimer's pharmacotherapy? 105
Polymorphism C in the serotonin transporter gene in depression-free elderly patients with vascular dementia 104
The potential of solanezumab and gantenerumab to prevent Alzheimer's disease in people with inherited mutations that cause its early onset 104
Age-related changes of serum N-acetyl-aspartate in healthy controls. 103
BACE inhibitors in clinical development for the treatment of Alzheimer’s disease 102
Peripheral Antioxidant Markers in Mild Cognitive Impairment and its Progression to Dementia 101
Epidemiology of age related hearing loss: A review 101
Tau-directed approaches for the treatment of Alzheimers disease: Focus on leuco-methylthioninium 101
Hyperhomocysteinemia is an independent risk factor of atherosclerosis in patients with metabolic syndrome 101
Frailty syndrome and all-cause mortality in demented patients: the Italian Longitudinal Study on Aging. 100
Aluminium in the diet, cognitive decline and dementia. 100
Cognitive frailty: Predementia syndrome and vascular risk factors 99
All-cause mortality and competing risks of fatal and nonfatal vascular events in the Italian longitudinal study on aging: impact of lipoprotein(a) 99
Sex differences in the association of apolipoprotein E and angiotensin-converting enzyme gene polymorphisms with healthy aging and longevity: a population-based study from Southern Italy 99
Aluminum in the diet and Alzheimer's disease: from current epidemiology to possible disease-modifying treatment 99
Polymorphism C in the serotonin transporter gene (SLC6A4) in questionable dementia and Alzheimer's disease 98
Apolipoprotein E Genotypes in Hospitalized Elderly Patients with Vascular Dementia 97
Nutritional interventions and cognitive-related outcomes in patients with late-life cognitive disorders: A systematic review 97
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease 96
S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in predementia syndromes and Alzheimer's disease 95
Late-life depression, mild cognitive impairment, and dementia: possible continuum? 95
Cognitive frailty: a potential target for secondary prevention of dementia 95
Mediterranean diet and cognitive decline 93
Assessment of sense of taste in Italian centenarians 93
Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease. 92
Analysis of some aspects of learning and memorization processes in an adult population. 92
Postural and Balance Disorders in Patients with Parkinson's Disease: A Prospective Open-Label Feasibility Study with Two Months of Action Observation Treatment 92
Metabolic syndrome, mild cognitive impairment, and dementia 91
CIND and MCI in the Italian elderly: frequency, vascular risk factors, progression to dementia 91
Dietary unsaturated fatty acids and risk of mild cognitive impairment 91
A rehabilitation program for mild memory impairments. 91
Pharmacotherapy for the treatment of depression in patients with alzheimer’s disease: a treatment-resistant depressive disorder 91
Nutritional factors, cognitive decline, and dementia 90
Interleukin 6 variable number of tandem repeats (VNTR) gene polymorphism in centenarians 89
Heterogeneity of mild cognitive impairment and other predementia syndromes in progression to dementia 89
Acoustic analysis of swallowing sounds: a new technique for assessing dysphagia 89
Temporal relationship between depressive symptoms and cognitive impairment: the Italian Longitudinal Study on Aging 89
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants 89
Dietary intake of unsaturated fatty acids and age-related cognitive decline: A 8.5-year follow-up of the Italian Longitudinal Study on Aging 88
Botulinum toxin type A and a rehabilitation program in the treatment of Pisa syndrome in Parkinson's disease 88
Daily Function as Predictor of Dementia in Cognitive Impairment, No Dementia (CIND) and Mild Cognitive Impairment (MCI): An 8-Year Follow-Up in the ILSA Study 88
Frailty syndrome and the risk of vascular dementia: The Italian Longitudinal Study on Aging 88
Apathy and depressive symptoms in older people and incident myocardial infarction, stroke, and mortality: A systematic review and meta-analysis of individual participant data 88
National trends in total cholesterol obscure heterogeneous changes in HDL and non-HDL cholesterol and total-to-HDL cholesterol ratio: a pooled analysis of 458 population-based studies in Asian and Western countries 88
Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys 87
Current epidemiology of mild cognitive impairment and other predementia syndromes2 86
Impact of aging on the relationships between impairment of "Orientation" and "Recall" items of MMSE and mild to moderate mood disorders. 86
Efficacy and safety studies of gantenerumab in patients with Alzheimer's disease. 86
Alpha-2-macroglobulin gene, oxidized low-density lipoprotein receptor-1 locus, and sporadic Alzheimer's disease 85
Mediterranean diet, mild cognitive impairment, and Alzheimer's disease 85
Adherence to a Mediterranean dietary pattern and risk of Alzheimer's disease [7] 85
Amyloid-related imaging abnormalities associated with immunotherapy in Alzheimer's disease patients 85
Dietary fatty acids, age-related cognitive decline and mild cognitive impairment 85
Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease 85
Differences in allele frequencies of ACE I/D polymorphism between Northern and Southern Europe at different ages 84
Alcohol consumption, mild cognitive impairment, and progression to dementia 84
Analysis of individual items of mini-mental state examination in discrimination between normal and demented subjects 83
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: A pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults 83
Molecular determinants of human longevity 82
Angiotensin I converting enzyme (ACE) gene polymorphism in centenarians: different allele frequencies between the North and South of Europe 82
N-3 polyunsaturated fatty acids and statins in heart failure 82
Vascular risk factors, incidence of MCI, and rates of progression to dementia 82
Mediterranean diet in predementia and dementia syndromes 82
Is insulin resistant brain state a central feature of the metabolic-cognitive syndrome? 82
Dietary patterns, foods, and food groups: Relation to late-life cognitive disorders 82
Vascular risk and genetics of sporadic late-onset Alzheimer's disease 81
Association Analysis of GRIN2B, Encoding N-Methyl-D-Aspartate Receptor 2B Subunit, and Alzheimer's Disease 81
Alcohol Consumption in Predementia and Dementia Syndromes 81
Interleukin 6-174 G/C promoter and variable number of tandem repeats (VNTR) gene polymorphisms in sporadic Alzheimer's disease 81
Plant-based nutraceutical interventions against cognitive impairment and dementia: Meta-analytic evidence of efficacy of a standardized Gingko biloba extract 81
Nutrition, frailty, and Alzheimer's disease. 80
Moderate alcohol consumption, apolipoprotein E, and neuroprotection 80
Progression to dementia in probable and possible mild cognitive impairment 80
Executive Dysfunction Detected with the Frontal Assessment Battery in Alzheimer's Disease Versus Vascular Dementia 80
Monounsaturated fatty acids and neuroprotection. The results of a study of cognitive decline in old age. Is there a case for this treatment in multiple sclerosis? 79
Lipoproteins, vascular-related genetic factors, and human longevity 79
Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe 79
Totale 9.989
Salva come PNG Salva come JPEG
Categoria #
all - tutte 76.908
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.908
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.736 0 0 209 592 679 413 616 563 739 284 498 143
2020/20213.557 308 224 293 453 416 275 283 202 280 456 189 178
2021/20221.840 64 165 12 67 101 184 71 88 152 135 320 481
2022/20233.167 510 300 215 305 379 405 34 369 492 20 79 59
2023/20241.153 106 192 75 73 94 248 55 65 38 55 29 123
2024/2025524 92 79 353 0 0 0 0 0 0 0 0 0
Totale 21.357